for the Period Ended 31 January 2026
| Balance sheet | |
| Additional notes | |
| Balance sheet notes |
As at
| Notes | 2026 | 13 months to 31 January 2025 | |
|---|---|---|---|
|
|
£ |
£ |
|
| Fixed assets | |||
| Investments: | 3 |
|
|
| Total fixed assets: |
|
|
|
| Current assets | |||
| Cash at bank and in hand: |
|
|
|
| Total current assets: |
|
|
|
| Creditors: amounts falling due within one year: | 4 |
(
|
(
|
| Net current assets (liabilities): |
( |
( |
|
| Total assets less current liabilities: |
|
|
|
| Creditors: amounts falling due after more than one year: | 5 |
(
|
(
|
| Total net assets (liabilities): |
|
( |
|
| Capital and reserves | |||
| Called up share capital: |
|
|
|
| Other reserves: |
|
||
| Profit and loss account: |
( |
( |
|
| Total Shareholders' funds: |
|
( |
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 January 2026
Basis of measurement and preparation
Valuation information and policy
Other accounting policies
for the Period Ended 31 January 2026
| 2026 | 13 months to 31 January 2025 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 31 January 2026
Subsidiary undertakings: Cost or valuation at 1 February 2025 £517,243; reduction in deferred consideration (£275,687); revaluation £308,444; valuation at 31 January 2026 £550,000. The company owns 90% of the ordinary share capital of Im-Insured.com Limited, a company incorporated in England and Wales. During the year the deferred consideration payable to the vendors was revised by agreement and the cost of the investment was reduced accordingly. The investment was valued at 31 January 2026 by the director at fair value, on the basis of a multiple of the subsidiary's annual revenue. On the historical cost basis the investment would have been included at £241,556 (2025: £517,243). No deferred tax has been provided on the revaluation as a disposal of the shares is expected to qualify for the substantial shareholding exemption.
for the Period Ended 31 January 2026
| 2026 | 13 months to 31 January 2025 | |
|---|---|---|
| £ | £ | |
| Accruals and deferred income |
|
|
| Other creditors |
|
|
| Total |
|
|
for the Period Ended 31 January 2026
| 2026 | 13 months to 31 January 2025 | |
|---|---|---|
| £ | £ | |
| Other creditors |
|
|
| Total |
|
|